About: Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.82 (-2.63%)
SVRA NASDAQ Savara Inc
Loading watchlist status…
Savara Inc share price
SVRA price activity
Last Price
$4.820
Change (24hr)
-0.13 USD (2.63%)
Volume
1.40M
Volume (4w avg)
-
Open
$4.94
Day Range
$4.75 - $4.97
Previous Close
$4.95
Last Trade
30 Oct, 8:00 pm GMT+0
Delayed
30 Oct, 8:00 pm GMT+0
SVRA price performance
-0.82%
5D
-4.46%
1M
-20.07%
YTD
+16.14%
1Y
Delayed
30 Oct, 8:00 pm GMT+0
SVRA Market Signals